Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124630142 | 12463014 | 2 | F | 20160609 | 20160614 | 20160829 | PER | US-JNJFOC-20160522845 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124630142 | 12463014 | 1 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | UNKNOWN;UNKNOWN | 0 | 36 | MG | SUSTAINED RELEASE TABLETS | ||||||
| 124630142 | 12463014 | 2 | PS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 18 MG AND 27 MG TAKEN AT ONCE IN THE MORNING | N | UNKNOWN;UNKNOWN | 21121 | 45 | MG | SUSTAINED RELEASE TABLETS | |||||
| 124630142 | 12463014 | 3 | SS | METHYLPHENIDATE HYDROCHLORIDE. | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | 20 | MG | TABLETS | |||||||
| 124630142 | 12463014 | 4 | SS | METHYLPHENIDATE HYDROCHLORIDE. | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | 10 | MG | TABLETS | |||||||
| 124630142 | 12463014 | 5 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | 100 MG TABLETS | UNKNOWN | 0 | 100 | MG | TABLETS | BID | |||||
| 124630142 | 12463014 | 6 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | 200 MG TABLET STRENGTH | UNKNOWN | 0 | 400 | MG | TABLETS | BID | |||||
| 124630142 | 12463014 | 7 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | UNKNOWN | 0 | 200 | MG | TABLETS | BID | ||||||
| 124630142 | 12463014 | 8 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | 25 MG TABLETS | UNKNOWN | 0 | 75 | MG | TABLETS | BID | |||||
| 124630142 | 12463014 | 9 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | 25 MG TABLETS | UNKNOWN | 0 | 50 | MG | TABLETS | BID | |||||
| 124630142 | 12463014 | 10 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | UNKNOWN | 0 | 25 | MG | TABLETS | BID | ||||||
| 124630142 | 12463014 | 11 | C | PENICILLIN NOS | PENICILLIN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124630142 | 12463014 | 1 | Attention deficit/hyperactivity disorder |
| 124630142 | 12463014 | 2 | Attention deficit/hyperactivity disorder |
| 124630142 | 12463014 | 3 | Attention deficit/hyperactivity disorder |
| 124630142 | 12463014 | 4 | Attention deficit/hyperactivity disorder |
| 124630142 | 12463014 | 5 | Migraine |
| 124630142 | 12463014 | 6 | Migraine |
| 124630142 | 12463014 | 7 | Migraine |
| 124630142 | 12463014 | 8 | Migraine |
| 124630142 | 12463014 | 9 | Migraine |
| 124630142 | 12463014 | 10 | Migraine |
| 124630142 | 12463014 | 11 | Rheumatic fever |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124630142 | 12463014 | Drug ineffective | |
| 124630142 | 12463014 | Migraine | |
| 124630142 | 12463014 | Off label use | |
| 124630142 | 12463014 | Product use issue | |
| 124630142 | 12463014 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124630142 | 12463014 | 1 | 2014 | 0 | ||
| 124630142 | 12463014 | 4 | 2006 | 0 | ||
| 124630142 | 12463014 | 6 | 201512 | 0 |